🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Nicholas E. Connor

London School of Hygiene & Tropical Medicine

ORCID: 0000-0002-5013-407X

MedicineSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial”.

Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial

The Lancet Global Health(2022)10.1016/s2214-109x(22)00309-6

N/A

4.4DataRank · unranked

117 citations

John Changalucha, Hilary Whitworth, Lígia A. Pinto, Paul Mutani, Jackton Indangasi +18 more

Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults

Clinical Infectious Diseases(2023)10.1093/cid/ciad693

N/A

0.671DataRank · unranked

16 citations

Ken Liu, Édouard Lhomme, Julie Blie, John McCullough, Matthew Onorato +90 more

Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries

Trials(2021)10.1186/s13063-021-05035-9

N/A

0.630DataRank · unranked

18 citations

Édouard Lhomme, Mark Kieh, Abdoul Habib Béavogui, Stephen B. Kennedy, Seydou Doumbia +91 more

Long-term cellular immunity of vaccines for Zaire Ebola Virus Diseases

Nature Communications(2024)10.1038/s41467-024-51453-z

N/A

0.596DataRank · unranked

19 citations

Édouard Lhomme, Mélanie Huchon, Emile Foucat, Marion Bérerd-Camara, Lydia Guillaumat +94 more

Evaluation of waning of IgG antibody responses after rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccines: a modelling study from the PREVAC randomized trial

Emerging Microbes & Infections(2024)10.1080/22221751.2024.2432353

N/A

0.251DataRank · unranked

4 citations

Marie Alexandre, Mélanie Prague, Abdoul Habib Béavogui, Seydou Doumbia, Mark Kieh +94 more

Global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: a systematic review and modelling study

The Lancet Global Health(2020)10.1016/s2214-109x(19)30545-5

N/A

0DataRank · unranked

493 citations

You Li, Katherine L. O’Brien, Shabir A. Madhi, Marc‐Alain Widdowson, Peter Byass +75 more

Immunogenicity and Safety of One-Dose Human Papillomavirus Vaccine Compared With Two or Three Doses in Tanzanian Girls (DoRIS): An Open-Label, Randomised, Non-inferiority Trial

Obstetrical & Gynecological Survey(2023)10.1097/ogx.0000000000001135

N/A

0DataRank · unranked

1 citations

John Changalucha, Hilary Whitworth, Lígia A. Pinto, Paul Mutani, Jackton Indangasi +18 more